IBDEI00R ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,317,1,1,0)
 ;;=1^438.53
 ;;^UTILITY(U,$J,358.3,317,1,2,0)
 ;;=2^OTH PARALYTIC SYND, BILAT
 ;;^UTILITY(U,$J,358.3,317,2)
 ;;=^321176
 ;;^UTILITY(U,$J,358.3,318,0)
 ;;=438.6^^3^25^2
 ;;^UTILITY(U,$J,358.3,318,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,318,1,1,0)
 ;;=1^438.6
 ;;^UTILITY(U,$J,358.3,318,1,2,0)
 ;;=2^ALTERATIONS OF SENSATIONS
 ;;^UTILITY(U,$J,358.3,318,2)
 ;;=^328503
 ;;^UTILITY(U,$J,358.3,319,0)
 ;;=438.7^^3^25^22
 ;;^UTILITY(U,$J,358.3,319,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,319,1,1,0)
 ;;=1^438.7
 ;;^UTILITY(U,$J,358.3,319,1,2,0)
 ;;=2^DISTURBANCES OF VISION
 ;;^UTILITY(U,$J,358.3,319,2)
 ;;=^328504
 ;;^UTILITY(U,$J,358.3,320,0)
 ;;=438.81^^3^25^73
 ;;^UTILITY(U,$J,358.3,320,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,320,1,1,0)
 ;;=1^438.81
 ;;^UTILITY(U,$J,358.3,320,1,2,0)
 ;;=2^OTH LATE EFF CEREB DIS, APRAXI
 ;;^UTILITY(U,$J,358.3,320,2)
 ;;=^317922
 ;;^UTILITY(U,$J,358.3,321,0)
 ;;=438.82^^3^25^74
 ;;^UTILITY(U,$J,358.3,321,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,321,1,1,0)
 ;;=1^438.82
 ;;^UTILITY(U,$J,358.3,321,1,2,0)
 ;;=2^OTH LATE EFF CEREB DIS, DYSPHA
 ;;^UTILITY(U,$J,358.3,321,2)
 ;;=^317923
 ;;^UTILITY(U,$J,358.3,322,0)
 ;;=438.83^^3^25^27
 ;;^UTILITY(U,$J,358.3,322,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,322,1,1,0)
 ;;=1^438.83
 ;;^UTILITY(U,$J,358.3,322,1,2,0)
 ;;=2^FACIAL WEAKNESS
 ;;^UTILITY(U,$J,358.3,322,2)
 ;;=^328505
 ;;^UTILITY(U,$J,358.3,323,0)
 ;;=438.84^^3^25^6
 ;;^UTILITY(U,$J,358.3,323,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,323,1,1,0)
 ;;=1^438.84
 ;;^UTILITY(U,$J,358.3,323,1,2,0)
 ;;=2^ATAXIA
 ;;^UTILITY(U,$J,358.3,323,2)
 ;;=^328507
 ;;^UTILITY(U,$J,358.3,324,0)
 ;;=438.85^^3^25^97
 ;;^UTILITY(U,$J,358.3,324,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,324,1,1,0)
 ;;=1^438.85
 ;;^UTILITY(U,$J,358.3,324,1,2,0)
 ;;=2^VERTIGO
 ;;^UTILITY(U,$J,358.3,324,2)
 ;;=^328508
 ;;^UTILITY(U,$J,358.3,325,0)
 ;;=438.89^^3^25^72
 ;;^UTILITY(U,$J,358.3,325,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,325,1,1,0)
 ;;=1^438.89
 ;;^UTILITY(U,$J,358.3,325,1,2,0)
 ;;=2^OTH LATE EFF CEREB DIS
 ;;^UTILITY(U,$J,358.3,325,2)
 ;;=^317924
 ;;^UTILITY(U,$J,358.3,326,0)
 ;;=438.9^^3^25^96
 ;;^UTILITY(U,$J,358.3,326,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,326,1,1,0)
 ;;=1^438.9
 ;;^UTILITY(U,$J,358.3,326,1,2,0)
 ;;=2^UNSPEC LATE EFF CEREBRO DISEAS
 ;;^UTILITY(U,$J,358.3,326,2)
 ;;=^269757
 ;;^UTILITY(U,$J,358.3,327,0)
 ;;=440.21^^3^25^7
 ;;^UTILITY(U,$J,358.3,327,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,327,1,1,0)
 ;;=1^440.21
 ;;^UTILITY(U,$J,358.3,327,1,2,0)
 ;;=2^ATHERO, NAT ART EXTR W/CLAUD
 ;;^UTILITY(U,$J,358.3,327,2)
 ;;=^293885
 ;;^UTILITY(U,$J,358.3,328,0)
 ;;=440.22^^3^25^8
 ;;^UTILITY(U,$J,358.3,328,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,328,1,1,0)
 ;;=1^440.22
 ;;^UTILITY(U,$J,358.3,328,1,2,0)
 ;;=2^ATHERO, NAT ART OF EXTR W/PAIN
 ;;^UTILITY(U,$J,358.3,328,2)
 ;;=^293886
 ;;^UTILITY(U,$J,358.3,329,0)
 ;;=440.23^^3^25^10
 ;;^UTILITY(U,$J,358.3,329,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,329,1,1,0)
 ;;=1^440.23
 ;;^UTILITY(U,$J,358.3,329,1,2,0)
 ;;=2^ATHEROSCL/EXTRMTY W/ULCERA
 ;;^UTILITY(U,$J,358.3,329,2)
 ;;=^295739
 ;;^UTILITY(U,$J,358.3,330,0)
 ;;=440.24^^3^25^9
 ;;^UTILITY(U,$J,358.3,330,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,330,1,1,0)
 ;;=1^440.24
 ;;^UTILITY(U,$J,358.3,330,1,2,0)
 ;;=2^ATHEROSCL/EXTRMTY W/GANGR
 ;;^UTILITY(U,$J,358.3,330,2)
 ;;=^295740
 ;;^UTILITY(U,$J,358.3,331,0)
 ;;=440.29^^3^25^71
 ;;^UTILITY(U,$J,358.3,331,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,331,1,1,0)
 ;;=1^440.29
 ;;^UTILITY(U,$J,358.3,331,1,2,0)
 ;;=2^OTH ATHEROSCL/EXTRMTY
 ;;^UTILITY(U,$J,358.3,331,2)
 ;;=^295741
 ;;^UTILITY(U,$J,358.3,332,0)
 ;;=440.4^^3^25^18
 ;;^UTILITY(U,$J,358.3,332,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,332,1,1,0)
 ;;=1^440.4
 ;;^UTILITY(U,$J,358.3,332,1,2,0)
 ;;=2^Chr Total Occl Artery of Extrem
 ;;^UTILITY(U,$J,358.3,332,2)
 ;;=^335264
 ;;^UTILITY(U,$J,358.3,333,0)
 ;;=440.8^^3^25^11
 ;;^UTILITY(U,$J,358.3,333,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,333,1,1,0)
 ;;=1^440.8
 ;;^UTILITY(U,$J,358.3,333,1,2,0)
 ;;=2^ATHEROSCLEROSIS NEC
 ;;^UTILITY(U,$J,358.3,333,2)
 ;;=^11234
 ;;^UTILITY(U,$J,358.3,334,0)
 ;;=441.4^^3^25^12
 ;;^UTILITY(U,$J,358.3,334,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,334,1,1,0)
 ;;=1^441.4
 ;;^UTILITY(U,$J,358.3,334,1,2,0)
 ;;=2^Abdm Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,334,2)
 ;;=^269769
 ;;^UTILITY(U,$J,358.3,335,0)
 ;;=V46.2^^3^25^76
 ;;^UTILITY(U,$J,358.3,335,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,335,1,1,0)
 ;;=1^V46.2
 ;;^UTILITY(U,$J,358.3,335,1,2,0)
 ;;=2^OTHER DEPEND ON SUPLEM OXYG
 ;;^UTILITY(U,$J,358.3,335,2)
 ;;=^328702
 ;;^UTILITY(U,$J,358.3,336,0)
 ;;=V66.7^^3^25^25
 ;;^UTILITY(U,$J,358.3,336,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,336,1,1,0)
 ;;=1^V66.7
 ;;^UTILITY(U,$J,358.3,336,1,2,0)
 ;;=2^ENCOUNTER-PALLIATIVE CARE
 ;;^UTILITY(U,$J,358.3,336,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,337,0)
 ;;=789.1^^3^25^31
 ;;^UTILITY(U,$J,358.3,337,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,337,1,1,0)
 ;;=1^789.1
 ;;^UTILITY(U,$J,358.3,337,1,2,0)
 ;;=2^HEPATOMEGALY
 ;;^UTILITY(U,$J,358.3,337,2)
 ;;=^56494
 ;;^UTILITY(U,$J,358.3,338,0)
 ;;=789.2^^3^25^94
 ;;^UTILITY(U,$J,358.3,338,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,338,1,1,0)
 ;;=1^789.2
 ;;^UTILITY(U,$J,358.3,338,1,2,0)
 ;;=2^SPLENOMEGALY
 ;;^UTILITY(U,$J,358.3,338,2)
 ;;=^113452
 ;;^UTILITY(U,$J,358.3,339,0)
 ;;=331.0^^3^25^3
 ;;^UTILITY(U,$J,358.3,339,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,339,1,1,0)
 ;;=1^331.0
 ;;^UTILITY(U,$J,358.3,339,1,2,0)
 ;;=2^ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,339,2)
 ;;=^5679
 ;;^UTILITY(U,$J,358.3,340,0)
 ;;=332.0^^3^25^79
 ;;^UTILITY(U,$J,358.3,340,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,340,1,1,0)
 ;;=1^332.0
 ;;^UTILITY(U,$J,358.3,340,1,2,0)
 ;;=2^PARKINSON'S
 ;;^UTILITY(U,$J,358.3,340,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,341,0)
 ;;=340.^^3^25^68
 ;;^UTILITY(U,$J,358.3,341,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,341,1,1,0)
 ;;=1^340.
 ;;^UTILITY(U,$J,358.3,341,1,2,0)
 ;;=2^MULTIPLE SCLEROSIS
 ;;^UTILITY(U,$J,358.3,341,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,342,0)
 ;;=042.^^3^25^33
 ;;^UTILITY(U,$J,358.3,342,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,342,1,1,0)
 ;;=1^042.
 ;;^UTILITY(U,$J,358.3,342,1,2,0)
 ;;=2^HIV DISEASE
 ;;^UTILITY(U,$J,358.3,342,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,343,0)
 ;;=309.81^^3^25^82
 ;;^UTILITY(U,$J,358.3,343,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,343,1,1,0)
 ;;=1^309.81
 ;;^UTILITY(U,$J,358.3,343,1,2,0)
 ;;=2^POSTTRAUMATIC STRESS DIS
 ;;^UTILITY(U,$J,358.3,343,2)
 ;;=^114692
 ;;^UTILITY(U,$J,358.3,344,0)
 ;;=344.1^^3^25^78
 ;;^UTILITY(U,$J,358.3,344,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,344,1,1,0)
 ;;=1^344.1
 ;;^UTILITY(U,$J,358.3,344,1,2,0)
 ;;=2^PARAPLEGIA NOS
 ;;^UTILITY(U,$J,358.3,344,2)
 ;;=^90028
 ;;^UTILITY(U,$J,358.3,345,0)
 ;;=344.00^^3^25^87
 ;;^UTILITY(U,$J,358.3,345,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,345,1,1,0)
 ;;=1^344.00
 ;;^UTILITY(U,$J,358.3,345,1,2,0)
 ;;=2^QUADRIPLEGIA, UNSP
 ;;^UTILITY(U,$J,358.3,345,2)
 ;;=^101908
 ;;^UTILITY(U,$J,358.3,346,0)
 ;;=344.01^^3^25^83
 ;;^UTILITY(U,$J,358.3,346,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,346,1,1,0)
 ;;=1^344.01
 ;;^UTILITY(U,$J,358.3,346,1,2,0)
 ;;=2^QUADRIPLEGIA C1-C4, COMPL
 ;;^UTILITY(U,$J,358.3,346,2)
 ;;=^303270
 ;;^UTILITY(U,$J,358.3,347,0)
 ;;=344.02^^3^25^84
 ;;^UTILITY(U,$J,358.3,347,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,347,1,1,0)
 ;;=1^344.02
 ;;^UTILITY(U,$J,358.3,347,1,2,0)
 ;;=2^QUADRIPLEGIA C1-C4, INC
 ;;^UTILITY(U,$J,358.3,347,2)
 ;;=^303271
 ;;^UTILITY(U,$J,358.3,348,0)
 ;;=344.03^^3^25^85
 ;;^UTILITY(U,$J,358.3,348,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,348,1,1,0)
 ;;=1^344.03
 ;;^UTILITY(U,$J,358.3,348,1,2,0)
 ;;=2^QUADRIPLEGIA C5-C7, COMPL
 ;;^UTILITY(U,$J,358.3,348,2)
 ;;=^303272
 ;;^UTILITY(U,$J,358.3,349,0)
 ;;=344.04^^3^25^86
 ;;^UTILITY(U,$J,358.3,349,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,349,1,1,0)
 ;;=1^344.04
 ;;^UTILITY(U,$J,358.3,349,1,2,0)
 ;;=2^QUADRIPLEGIA C5-C7, INC
 ;;^UTILITY(U,$J,358.3,349,2)
 ;;=^303273
 ;;^UTILITY(U,$J,358.3,350,0)
 ;;=344.09^^3^25^77
 ;;^UTILITY(U,$J,358.3,350,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,350,1,1,0)
 ;;=1^344.09
 ;;^UTILITY(U,$J,358.3,350,1,2,0)
 ;;=2^OTHER QUADRIPLEGIA
 ;;^UTILITY(U,$J,358.3,350,2)
 ;;=^303274
 ;;^UTILITY(U,$J,358.3,351,0)
 ;;=344.2^^3^25^21
 ;;^UTILITY(U,$J,358.3,351,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,351,1,1,0)
 ;;=1^344.2
 ;;^UTILITY(U,$J,358.3,351,1,2,0)
 ;;=2^DIPLEGIA OF UPPER LIMBS
 ;;^UTILITY(U,$J,358.3,351,2)
 ;;=^268452
 ;;^UTILITY(U,$J,358.3,352,0)
 ;;=344.30^^3^25^67
 ;;^UTILITY(U,$J,358.3,352,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,352,1,1,0)
 ;;=1^344.30
 ;;^UTILITY(U,$J,358.3,352,1,2,0)
 ;;=2^MONOPLEG, LL, UNSP
 ;;^UTILITY(U,$J,358.3,352,2)
 ;;=^303275
 ;;^UTILITY(U,$J,358.3,353,0)
 ;;=344.31^^3^25^65
 ;;^UTILITY(U,$J,358.3,353,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,353,1,1,0)
 ;;=1^344.31
 ;;^UTILITY(U,$J,358.3,353,1,2,0)
 ;;=2^MONOPLEG, LL, DOM.
 ;;^UTILITY(U,$J,358.3,353,2)
 ;;=^303276
 ;;^UTILITY(U,$J,358.3,354,0)
 ;;=344.32^^3^25^66
 ;;^UTILITY(U,$J,358.3,354,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,354,1,1,0)
 ;;=1^344.32
 ;;^UTILITY(U,$J,358.3,354,1,2,0)
 ;;=2^MONOPLEG, LL, NONDOM.
 ;;^UTILITY(U,$J,358.3,354,2)
 ;;=^303277
 ;;^UTILITY(U,$J,358.3,355,0)
 ;;=344.60^^3^25^14
 ;;^UTILITY(U,$J,358.3,355,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,355,1,1,0)
 ;;=1^344.60
 ;;^UTILITY(U,$J,358.3,355,1,2,0)
 ;;=2^CAUDA EQUINA SYND NOS
 ;;^UTILITY(U,$J,358.3,355,2)
 ;;=^268459
 ;;^UTILITY(U,$J,358.3,356,0)
 ;;=344.61^^3^25^69
 ;;^UTILITY(U,$J,358.3,356,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,356,1,1,0)
 ;;=1^344.61
 ;;^UTILITY(U,$J,358.3,356,1,2,0)
 ;;=2^NEUROGENIC BLADDER
